annual cash & cash equivalents:
$430.61M+$411.40M(+2142.15%)Summary
- As of today (June 17, 2025), JANX annual cash & cash equivalents is $430.61 million, with the most recent change of +$411.40 million (+2142.15%) on December 31, 2024.
- During the last 3 years, JANX annual cash & cash equivalents has risen by +$395.02 million (+1110.18%).
- JANX annual cash & cash equivalents is now at all-time high.
Performance
JANX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$73.74M-$356.86M(-82.87%)Summary
- As of today (June 17, 2025), JANX quarterly cash & cash equivalents is $73.74 million, with the most recent change of -$356.86 million (-82.87%) on March 31, 2025.
- Over the past year, JANX quarterly cash & cash equivalents has dropped by -$139.06 million (-65.35%).
- JANX quarterly cash & cash equivalents is now -82.87% below its all-time high of $430.61 million, reached on December 31, 2024.
Performance
JANX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
JANX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2142.2% | -65.3% |
| 3 y3 years | +1110.2% | +33.8% |
| 5 y5 years | +10000.0% | - |
JANX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2142.2% | -82.9% | +402.9% |
| 5 y | 5-year | at high | >+9999.0% | -82.9% | +843.9% |
| alltime | all time | at high | >+9999.0% | -82.9% | +843.9% |
JANX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $73.74M(-82.9%) |
| Dec 2024 | $430.61M(+2142.2%) | $430.61M(+1509.5%) |
| Sep 2024 | - | $26.75M(+82.5%) |
| Jun 2024 | - | $14.66M(-93.1%) |
| Mar 2024 | - | $212.80M(+1008.1%) |
| Dec 2023 | $19.20M(-62.7%) | $19.20M(+12.0%) |
| Sep 2023 | - | $17.15M(-49.1%) |
| Jun 2023 | - | $33.70M(+11.0%) |
| Mar 2023 | - | $30.36M(-41.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $51.43M(+44.5%) | $51.43M(-20.6%) |
| Sep 2022 | - | $64.75M(+10.9%) |
| Jun 2022 | - | $58.40M(+5.9%) |
| Mar 2022 | - | $55.13M(+54.9%) |
| Dec 2021 | $35.58M(+355.4%) | $35.58M(-9.7%) |
| Sep 2021 | - | $39.39M(-84.3%) |
| Jun 2021 | - | $251.63M(+255.6%) |
| Mar 2021 | - | $70.77M(+805.8%) |
| Dec 2020 | $7.81M(+1087.4%) | $7.81M |
| Dec 2019 | $658.00K | - |
FAQ
- What is Janux Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Janux Therapeutics?
- What is Janux Therapeutics annual cash & cash equivalents year-on-year change?
- What is Janux Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Janux Therapeutics?
- What is Janux Therapeutics quarterly cash & cash equivalents year-on-year change?
What is Janux Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of JANX is $430.61M
What is the all time high annual cash & cash equivalents for Janux Therapeutics?
Janux Therapeutics all-time high annual cash & cash equivalents is $430.61M
What is Janux Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, JANX annual cash & cash equivalents has changed by +$411.40M (+2142.15%)
What is Janux Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of JANX is $73.74M
What is the all time high quarterly cash & cash equivalents for Janux Therapeutics?
Janux Therapeutics all-time high quarterly cash & cash equivalents is $430.61M
What is Janux Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, JANX quarterly cash & cash equivalents has changed by -$139.06M (-65.35%)